Category: Research

Everything You Need to Know About FFB Canada’s Patient Registry

February 6th, 2018 by FFB Canada

Fill out the online form on our Patient Registry page to learn more about how you can enroll. Click here to download a printable version of this article/fact sheet: PDF/Word. The Patient Registry is a secure medical database that was designed to connect people living with inherited retinal diseases (IRDs) to clinical trials, to improve…

Read More

First gene therapy for a blinding eye disease receives FDA approval

December 19th, 2017 by Dr. Mary Sunderland

Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the US that targets a disease caused by mutations in a specific gene. The next steps involve determining the price for Luxturna, which poses…

Read More

Survival of the Fittest: Sustaining Cells Through Transplantation

December 18th, 2017 by Dr. Chad Andrews

In many retinal diseases, vision loss occurs when cells that are crucial for vision are damaged or lost. This is the case, for example, in age-related macular degeneration (AMD), retinitis pigmentosa, choroideremia, and Stargardt disease. To reverse vision loss resulting from these and similar diseases, we need to develop and refine our ability to replace…

Read More

Understanding the Retina: AMD and Exploratory Science

December 1st, 2017 by Dr. Chad Andrews

In medicine, innovative treatments don’t emerge out of thin air; they are the result of a series of advancements in our understanding of how genes, molecules, and cells interact. The human eye is no stranger to this rule. In fact, there is still much we don’t understand about the genetic and cellular foundations of sight….

Read More

The Value of iPSCs for Stem Cell Therapy

November 22nd, 2017 by Dr. Chad Andrews

Stem cell therapy has emerged as one of the most promising approaches in the fight to end blindness, and Dr. Gilbert Bernier’s research has played an enormous role in pushing the field forward. By developing new techniques to turn induced pluripotent stem cells (iPSCs) into sheets of cone photoreceptors, Dr. Bernier and his team are…

Read More

Clinician-Scientist Emerging Leader Award: Dr. Brian Ballios

November 1st, 2017 by FFB Canada

UPDATE: With Dr. Brian Ballios launching our Let’s Bring the Fight campaign, we wanted to re-publish this post about him being our inaugural recipient of the Foundation Fighting Blindness Clinician-Scientist Emerging Leader Award. Dr. Brian Ballios has restored vision in mice, but he is not stopping there. He is on a mission to develop stem…

Read More

New Master Control Gene Provides Key Insights into Restoring Vision

October 31st, 2017 by Dr. Chad Andrews

With support from the FFB community, Dr. Michel Cayouette’s research is advancing the field of stem cell therapy in extraordinary ways; it is doing so by illuminating how stem cells are produced, how they turn into other cells, and the role they play in the overall biology of the human eye. Dr. Cayouette’s ultimate goal?…

Read More

FDA Panel Votes Unanimously to Approve New Gene Therapy

October 13th, 2017 by Dr. Mary Sunderland

History was made on World Sight Day, October 12, 2017, when an FDA advisory panel voted unanimously to approve a new gene therapy, Luxturna, designed to treat inherited blinding eye diseases caused by mutations in the RPE65 gene. We have been following this story closely over the past few years and celebrating every milestone along…

Read More

Let’s Talk Technology With Dr. Mary Sunderland [September 2017 Facebook Live](VIDEO)

September 19th, 2017 by FFB Canada

On the first Tuesday of every month, the Foundation Fighting Blindness sends out our e-newsletter featuring the latest and most exciting research breakthroughs. Soon after each e-newsletter, our very own Director of Research and Education, Dr. Mary Sunderland, takes to our Facebook page to do a live broadcast discussion of the articles featured in the…

Read More

Could Artificial Intelligence Revolutionize the Treatment of Eye Diseases?

September 5th, 2017 by Dr. Chad Andrews

Artificial intelligence is in the news more frequently than ever, but it’s not typically associated with vision research. That may not be the case for long: incredible progress is being made in the application of artificial intelligence (AI) to the detection and prognosis of eye diseases such as age-related macular degeneration (AMD) and diabetic retinopathy….

Read More